NEW YORK, June 29, 2023 /PRNewswire/ -- Cresilon, Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that it has been granted ...
NEW YORK, March 25, 2026 /PRNewswire/ -- Cresilon has been named to Fast Company's World's 50 Most Innovative Companies of 2026. The company ranked No. 1 in the medical devices category and No. 46 ...
Ranked No. 1 in the medical devices category and No. 46 on Fast Company's World's 50 Most Innovative Companies list NEW YORK, March 25, 2026 /PRNewswire/ -- Cresilon has been named to Fast Company's ...
Cresilon has raised $38.5 million in funding to expand production and launch of its plant-based hydrogel products, which stop traumatic bleeding on contact. Cresilon was cofounded in 2010 by Joe ...
NEW YORK, March 2, 2026 /PRNewswire/ -- Cresilon announced its revolutionary hemostatic gel TRAUMAGEL® has received an Innovative Technology contract from Vizient® the nation's largest provider-driven ...
The Cobb County fire department is one of the first agencies in the country to use a revolutionary new gel that quickly stops bleeding. The plant-based gel can control severe bleeding in seconds, ...
VETIGEL, a revolutionary plant-based hemostatic gel that instantly stops and controls bleeding, is now available for veterinarian surgeons across Canada through McCarthy Vet. The agreement with ...